Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Patients With Taxane-Resistant Metastatic Breast CancerEva Thomas, Miguel Martín, Linda T. Vahdat et al.|Journal of Clinical Oncology|2007Cited by 290
Phase III Study of Gemcitabine Plus Docetaxel Compared With Capecitabine Plus Docetaxel for Anthracycline-Pretreated Patients With Metastatic Breast CancerStephen Chan, P. Fumoleau, Gilles Romieu et al.|Journal of Clinical Oncology|2009Cited by 119
Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancerFrancesco Caponigro, P. Fumoleau, Christian Dittrich et al.|European Journal of Cancer|2002Cited by 28